PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 60 filers reported holding PDS BIOTECHNOLOGY CORP in Q3 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,548 | -44.3% | 25,851 | -32.2% | 0.00% | -50.0% |
| Q1 2023 | $234,377 | -26.3% | 38,110 | +58.1% | 0.01% | -33.3% |
| Q4 2022 | $318,226 | +478.6% | 24,108 | +59.1% | 0.01% | +350.0% |
| Q2 2022 | $55,000 | -89.5% | 15,151 | -82.1% | 0.00% | -92.0% |
| Q1 2022 | $524,000 | +49.3% | 84,587 | +95.1% | 0.02% | +13.6% |
| Q4 2021 | $351,000 | -44.5% | 43,366 | +2.3% | 0.02% | -56.0% |
| Q3 2021 | $632,000 | – | 42,386 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 117,242 | $311,000 | 0.07% |
| Andesa Financial Management Inc. | 16,655 | $44,000 | 0.04% |
| Sofinnova Investments, Inc. | 142,635 | $378,000 | 0.03% |
| INSPIRION WEALTH ADVISORS, LLC | 22,875 | $61,000 | 0.02% |
| REGENTATLANTIC CAPITAL LLC | 15,753 | $42,000 | 0.00% |
| Ellis Investment Partners, LLC | 2,250 | $5,000 | 0.00% |
| tru Independence LLC | 500 | $0 | 0.00% |
| Renaissance Technologies | 120,269 | $319,000 | 0.00% |
| D. E. Shaw & Co., Inc. | 13,281 | $35,000 | 0.00% |
| VANGUARD GROUP INC | 36,206 | $96,000 | 0.00% |